Steve Braunstein, MD
Enriched profileAssociate Professor and Vice Chair, Department of Radiation Oncology · University of California, San Francisco (UCSF)
Steve Braunstein is Associate Professor and Vice Chair, Department of Radiation Oncology at University of California, San Francisco (UCSF). OpenAlex indexes 527 publications with 10,221 citations (h-index 52); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 26 Oct 2026
Overview
Updated 27 Oct 2026
Steve Braunstein, MD, PHD, is Associate Professor and Vice Chair, Department of Radiation Oncology at University of California, San Francisco (UCSF). The public record shows 527 publications with 10,221 citations (h-index 52), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Management of metastatic bone disease. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (2025–2026).
- Most recent indexed publication: 2026 · Neuro-oncology practice
- Top research focus: Glioma Diagnosis and Treatment
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 144.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
Sponsor: University of California, San Francisco
- Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
Sponsor: Nancy Ann Oberheim Bush, MD
Industry payments
Updated 26 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novocure Inc.Program year20257 payments
- GT Medical Technologies, IncProgram year20253 payments
- icotec Medical Inc.Program year20258 payments
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Corticosteroid100%Dexamethasone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 26 Oct 2026
1 NIH research award on record, funded 2025–2026 per NIH RePORTER. The latest:
- Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity
University of California, San Francisco
FY2026$713,733R01CA292043 - Development of a Personalized Voxel-wise Prediction of Brain Metastases using Multi-Parametric MR Imaging to Reduce Treatment Toxicity
University of California, San Francisco
FY2025$729,587R01CA292043
Congress activity
Updated 26 Oct 2026
135 congress contributions (2004–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Impact of genomic subtype on intracranial outcomes in treatment-naive EGFR -mutant NSCLC with osimertinib (IGnITE).
ASCO Annual Meeting
ASCO2026Co-author - A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531)
ASTRO Annual Meeting
ASTRO2026Presenting author - Alteration Subtype is Prognostic of Intracranial Outcome and Predicts the Benefit of Upfront SRS in EGFR-Mutant NSCLC Brain Metastasis
ASTRO Annual Meeting
ASTRO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A multidisciplinary program for meningioma treatment, research, and support services.
Neuro-oncology practice
Article2026 - Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.
Journal of clinical oncology
Clinical Trial2026 - Natural language processing to identify documented pain preceding radiation therapy for bone metastases.
JNCI cancer spectrum
Article2026 - Unsupervised Large Language Models to Identify Topics in Cancer Center Patient Portal Messages.
JCO clinical cancer informatics
Article2025
Most-cited works
by citation count (OpenAlex)- 01Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T CellsArticle711 citations2008
- 02Estimating Survival in Patients With Lung Cancer and Brain MetastasesArticle662 citations2016
- 03
- 04A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast CancerArticle309 citations2007
- 05Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesArticle295 citations2022
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/steve-braunstein-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsf.edu ↗
- Vice-President
ADROP executive committee (ASTRO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →astro.org ↗ - Gray Zone Section Editor
International Journal of Radiation Oncology, Biology and Physics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →astro.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- AOA Inductee2008verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsf.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- UCSF Brain Tumor Center
Pediatric Malignancies Program, and Sarcoma Program (member)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.ucsf.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Gregory Marcus, MD
University of California, San Francisco (UCSF)
Eric Small, MD
University of California, San Francisco (UCSF)
Adam Boxer, MD
University of California, San Francisco (UCSF)
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center